Kaur, SavneetSavneetKaurKidambi, SriSriKidambiOrtega-Ribera, MartíMartíOrtega-RiberaThanh Thuy, Le ThiLe ThiThanh ThuyNieto, NataliaNataliaNietoCogger, Victoria CVictoria CCoggerXie, Wei-FenWei-FenXieTacke, FrankFrankTackeJordi, GraciaGraciaJordi2024-10-142024-10-142023https://boris-portal.unibe.ch/handle/20.500.12422/115698In vitro models of liver (patho)physiology, new technologies and experimental approaches are progressing rapidly. Based on cell lines, induced pluripotent stem cells (iPSCs) or primary cells derived from mouse or human liver as well as whole tissue (slices), such in vitro single- and multi-cellular models, including complex microfluidic organ-on-a-chip systems, provide tools to functionally understand mechanisms of liver health and disease. The International Society of Hepatic Sinusoidal Research (ISHSR) commissioned this working group to review the currently available in vitro liver models and describe the advantages and disadvantages of each in the context of evaluating their use for the study of liver functionality, disease modelling, therapeutic discovery and clinical applicability.enHepatic sinusoid NAFLD NASH bioengineering cirrhosis mechanobiology omics600 - Technology::610 - Medicine & healtharticle10.48350/1752733644281210.1016/j.jcmgh.2022.11.008